ImageneBio, Inc.
IMA
$5.84
-$0.03-0.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.19% | -74.74% | -43.56% | -678.48% | -21.19% |
| Total Depreciation and Amortization | 114.63% | 117.50% | 496.81% | 106.67% | -85.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 229.82% | 396.57% | 200.00% | 1,080.81% | -- |
| Change in Net Operating Assets | 100.47% | -271.02% | -170.38% | -1,173.23% | -1,574.91% |
| Cash from Operations | 23.76% | -104.70% | -107.71% | -694.35% | -99.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -1,424.27% | -612.08% | -- |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -22.22% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,514.42% | -18,116.67% | 100.00% | -- | -- |
| Cash from Financing | 115.47% | -12,114.81% | -100.00% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -60.00% | 485.84% | 85.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,588.94% | -156.72% | -346.29% | 5,734.63% | 118.19% |